Gene activation by metazoan enhancers: Diverse mechanisms stimulate distinct steps of transcription

BioEssays

Volumn 38, Issue 9, 2016, Pages 881-893

  Beagrie, Robert A ^a   Pombo, Ana ^a  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

enhancer; eRNA; gene regulation; massively parallel reporter assay; mediator; transcription factors

Indexed keywords

LONG UNTRANSLATED RNA; POLYCOMB GROUP PROTEIN; RNA POLYMERASE; RNA POLYMERASE II; TRANSCRIPTION FACTOR;

ARTICLE; ASSAY; CHROMATIN; CRISPR CAS SYSTEM; ENHANCER REGION; ENZYME RELEASE; GENE; GENE ACTIVATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; NONHUMAN; PROMOTER REGION; TRANSACTIVATION;

EID: 84983407807     PISSN: 02659247     EISSN: 15211878     Source Type: Journal    
DOI: 10.1002/bies.201600032     Document Type: Article

References (121)

1. Banerji J, Rusconi S, Schaffner W. 1981. Expression of a beta-globin gene is enhanced by remote SV40 DNA sequences. Cell 27: 299–308.
2. Pennacchio LA, Bickmore W, Dean A, Nobrega MA, et al. 2013. Enhancers: five essential questions. Nat Rev Genet 14: 288–95.
3. Andersson R, Gebhard C, Miguel-Escalada I, Hoof I, et al. 2014. An atlas of active enhancers across human cell types and tissues. Nature 507: 455–61.
4. Corradin O, Scacheri PC. 2014. Enhancer variants: evaluating functions in common disease. Genome Med 6: 85.
5. Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, et al. 2009. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci USA 106: 9362–7.
6. Frietze S, Farnham PJ. 2011. A Handbook of Transcription Factors. Dordrecht, Netherlands: Springer. p. 261–77.
7. Spitz F, Furlong EEM. 2012. Transcription factors: from enhancer binding to developmental control. Nat Rev Genet 13: 613–26.
8. Lettice LA, Horikoshi T, Heaney SJH, van Baren MJ, et al. 2002. Disruption of a long-range cis-acting regulator for Shh causes preaxial polydactyly. Proc Natl Acad Sci USA 99: 7548–53.
9. Philipsen S, Talbot D, Fraser P, Grosveld F. 1990. The beta-globin dominant control region: hypersensitive site 2. EMBO J 9: 2159–67.
10. Talbot D, Philipsen S, Fraser P, Grosveld F. 1990. Detailed analysis of the site 3 region of the human beta-globin dominant control region. EMBO J 9: 2169–77.
11. Roberts SG, Choy B, Walker SS, Lin YS, et al. 1995. A role for activator-mediated TFIIB recruitment in diverse aspects of transcriptional regulation. Curr Biol 5: 508–16.
12. Fry CJ, Slansky JE, Farnham PJ. 1997. Position-dependent transcriptional regulation of the murine dihydrofolate reductase promoter by the E2F transactivation domain. Mol Cell Biol 17: 1966–76.
13. Dobi KC, Winston F. 2007. Analysis of transcriptional activation at a distance in Saccharomyces cerevisiae. Mol Cell Biol 27: 5575–86.
14. Reavey CT, Hickman MJ, Dobi KC, Botstein D, et al. 2015. Analysis of polygenic mutants suggests a role for mediator in regulating transcriptional activation distance in Saccharomyces cerevisiae. Genetics 201: 599–612.
15. Seipel K, Georgiev O, Schaffner W. 1992. Different activation domains stimulate transcription from remote (‘enhancer’) and proximal (‘promoter’) positions. EMBO J 11: 4961–8.
16. Cheng Y, Ma Z, Kim B-H, Wu W, et al. 2014. Principles of regulatory information conservation between mouse and human. Nature 515: 371–5.
17. Weil PA, Luse DS, Segall J, Roeder RG. 1979. Selective and accurate initiation of transcription at the Ad2 major late promotor in a soluble system dependent on purified RNA polymerase II and DNA. Cell 18: 469–84.
18. Thomas MC, Chiang C-M. 2006. The general transcription machinery and general cofactors. Crit Rev Biochem Mol Biol 41: 105–78.
19. Saunders A, Core LJ, Lis JT. 2006. Breaking barriers to transcription elongation. Nat Rev Mol Cell Biol 7: 557–67.
20. Kim YJ, Björklund S, Li Y, Sayre MH, et al. 1994. A multiprotein mediator of transcriptional activation and its interaction with the C-terminal repeat domain of RNA polymerase II. Cell 77: 599–608.
21. Allen BL, Taatjes DJ. 2015. The Mediator complex: a central integrator of transcription. Nat Rev Mol Cell Biol 16: 155–66.
22. Conaway RC, Conaway JW. 2011. Origins and activity of the Mediator complex. Semin Cell Dev Biol 22: 729–34.
23. Visel A, Blow MJ, Li Z, Zhang T, et al. 2009. ChIP-seq accurately predicts tissue-specific activity of enhancers. Nature 457: 854–8.
24. Heintzman ND, Stuart RK, Hon G, Fu Y, et al. 2007. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat Genet 39: 311–8.
25. Hilton IB, D'Ippolito AM, Vockley CM, Thakore PI, et al. 2015. Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers. Nat Biotechnol 33: 510–7.
26. Mendenhall EM, Williamson KE, Reyon D, Zou JY, et al. 2013. Locus-specific editing of histone modifications at endogenous enhancers. Nat Biotechnol 31: 1133–6.
27. Kearns NA, Pham H, Tabak B, Genga RM, et al. 2015. Functional annotation of native enhancers with a Cas9-histone demethylase fusion. Nat Methods 12: 401–3.
28. Yu Y, Chen Y, Kim B, Wang H, et al. 2013. Olig2 targets chromatin remodelers to enhancers to initiate oligodendrocyte differentiation. Cell 152: 248–61.
29. Shi J, Whyte WA, Zepeda-Mendoza CJ, Milazzo JP, et al. 2013. Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation. Genes Dev 27: 2648–62.
30. Pulakanti K, Pinello L, Stelloh C, Blinka S, et al. 2013. Enhancer transcribed RNAs arise from hypomethylated, Tet-occupied genomic regions. Epigenetics 8: 1303–20.
31. Vernimmen D, Lynch MD, De Gobbi M, Garrick D, et al. 2011. Polycomb eviction as a new distant enhancer function. Genes Dev 25: 1583–8.
32. Kondo T, Isono K, Kondo K, Endo TA, et al. 2014. Polycomb potentiates Meis2 activation in midbrain by mediating interaction of the promoter with a tissue-specific enhancer. Dev Cell 28: 94–101.
33. Montavon T, Duboule D. 2013. Chromatin organization and global regulation of Hox gene clusters. Philos Trans R Soc B Biol Sci 368: 20120367.
34. Noordermeer D, Leleu M, Splinter E, Rougemont J, et al. 2011. The dynamic architecture of Hox gene clusters. Science 334: 222–5.
35. Montavon T, Soshnikova N, Mascrez B, Joye E, et al. 2011. A regulatory archipelago controls Hox genes transcription in digits. Cell 147: 1132–45.
36. Andrey G, Montavon T, Mascrez B, Gonzalez F, et al. 2013. A switch between topological domains underlies HoxD genes collinearity in mouse limbs. Science 340: 1234167.
37. Williams K, Christensen J, Rappsilber J, Nielsen AL, et al. 2014. The histone lysine demethylase JMJD3/KDM6B is recruited to p53 bound promoters and enhancer elements in a p53 dependent manner. PLoS ONE 9: 9e96545.
38. Kondo T, Ito S, Koseki H. 2016. Polycomb in transcriptional phase transition of developmental genes. Trends Biochem Sci 41: 9–19.
39. Adelman K, Lis JT. 2012. Promoter-proximal pausing of RNA polymerase II: emerging roles in metazoans. Nat Rev Genet 13: 720–31.
40. Liu W, Ma Q, Wong K, Li W, et al. 2013. Brd4 and JMJD6-associated anti-pause enhancers in regulation of transcriptional pause release. Cell 155: 1581–95.
41. Lovén J, Hoke HA, Lin CY, Lau A, et al. 2013. Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell 153: 320–34.
42. Zhang W, Prakash C, Sum C, Gong Y, et al. 2012. Bromodomain-containing protein 4 (BRD4) regulates RNA polymerase II serine 2 phosphorylation in human CD4+ T cells. J Biol Chem 287: 43137–55.
43. Anand P, Brown JD, Lin CY, Qi J, et al. 2013. BET bromodomains mediate transcriptional pause release in heart failure. Cell 154: 569–82.
44. Eberhardy SR, Farnham PJ. 2002. Myc recruits P-TEFb to mediate the final step in the transcriptional activation of the cad promoter. J Biol Chem 277: 40156–62.
45. Sabò A, Kress TR, Pelizzola M, de Pretis S, et al. 2014. Selective transcriptional regulation by Myc in cellular growth control and lymphomagenesis. Nature 511: 488–92.
46. Lin C, Garruss AS, Luo Z, Guo F, et al. 2013. The RNA Pol II elongation factor Ell3 marks enhancers in ES cells and primes future gene activation. Cell 152: 144–56.
47. Kaikkonen MU, Niskanen H, Romanoski CE, Kansanen E, et al. 2014. Control of VEGF-A transcriptional programs by pausing and genomic compartmentalization. Nucleic Acids Res 42: 12570–84.
48. Shang Y, Myers M, Brown M. 2002. Formation of the androgen receptor transcription complex. Mol Cell 9: 601–10.
49. Johnson KD, Christensen HM, Zhao B, Bresnick EH. 2001. Distinct mechanisms control RNA polymerase II recruitment to a tissue-specific locus control region and a downstream promoter. Mol Cell 8: 465–71.
50. Vieira KF, Levings PP, Hill MA, Crusselle VJ, et al. 2004. Recruitment of transcription complexes to the β-globin gene locus in vivo and in vitro. J Biol Chem 279: 50350–7.
51. Kim T-K, Hemberg M, Gray JM, Costa AM, et al. 2010. Widespread transcription at neuronal activity-regulated enhancers. Nature 465: 182–7.
52. De Santa F, Barozzi I, Mietton F, Ghisletti S, et al. 2010. A large fraction of extragenic RNA pol II transcription sites overlap enhancers. PLoS Biol 8: e1000384.
53. Koch F, Fenouil R, Gut M, Cauchy P, et al. 2011. Transcription initiation platforms and GTF recruitment at tissue-specific enhancers and promoters. Nat Struct Mol Biol 18: 956–63.
54. Louie MC, Yang HQ, Ma A-H, Xu W, et al. 2003. Androgen-induced recruitment of RNA polymerase II to a nuclear receptor-p160 coactivator complex. Proc Natl Acad Sci USA 100: 2226–30.
55. Zhao H, Dean A. 2004. An insulator blocks spreading of histone acetylation and interferes with RNA polymerase II transfer between an enhancer and gene. Nucleic Acids Res 32: 4903–19.
56. Barrow JJ, Li Y, Hossain M, Huang S, et al. 2014. Dissecting the function of the adult β-globin downstream promoter region using an artificial zinc finger DNA-binding domain. Nucleic Acids Res 42: 4363–74.
57. Bulger M, Groudine M. 1999. Looping versus linking: toward a model for long-distance gene activation. Genes Dev 13: 2465–77.
58. Vernimmen D, Bickmore WA. 2015. The hierarchy of transcriptional activation: fFrom enhancer to promoter. Trends Genet 31: 696–708.
59. Zhu X, Ling J, Zhang L, Pi W, et al. 2007. A facilitated tracking and transcription mechanism of long-range enhancer function. Nucleic Acids Res 35: 5532–44.
60. Wang Q, Carroll JS, Brown M. 2005. Spatial and temporal recruitment of androgen receptor and its coactivators involves chromosomal looping and polymerase tracking. Mol Cell 19: 631–42.
61. Tuan D, Kong S, Hu K. 1992. Transcription of the hypersensitive site HS2 enhancer in erythroid cells. Proc Natl Acad Sci USA 89: 11219–23.
62. Szutorisz H, Canzonetta C, Georgiou A, Chow C, et al. 2005. Formation of an active tissue-specific chromatin domain initiated by epigenetic marking at the embryonic stem cell stage. Mol Cell Biol 25: 1804–20.
63. Ho Y, Elefant F, Liebhaber SA, Cooke NE. 2006. Locus control region transcription plays an active role in long-range gene activation. Mol Cell 23: 365–75.
64. Dillon N, Trimborn T, Strouboulis J, Fraser P, et al. 1997. The effect of distance on long-range chromatin interactions. Mol Cell 1: 131–9.
65. Blackwood EM, Kadonaga JT. 1998. Going the distance: a current view of enhancer action. Science 281: 60–3.
66. Hatzis P, Talianidis I. 2002. Dynamics of enhancer-promoter communication during differentiation-induced gene activation. Mol Cell 10: 1467–77.
67. Dixon JR, Selvaraj S, Yue F, Kim A, et al. 2012. Topological domains in mammalian genomes identified by analysis of chromatin interactions. Nature 485: 376–80.
68. Nora EP, Lajoie BR, Schulz EG, Giorgetti L, et al. 2012. Spatial partitioning of the regulatory landscape of the X-inactivation centre. Nature 485: 381–5.
69. Sanborn AL, Rao SSP, Huang S-C, Durand NC, et al. 2015. Chromatin extrusion explains key features of loop and domain formation in wild-type and engineered genomes. Proc Natl Acad Sci USA 112: E6456–65.
70. Rao SSP, Huntley MH, Durand NC, Stamenova EK, et al. 2014. A 3D map of the human genome at kilobase resolution reveals principles of chromatin looping. Cell 159: 1665–80.
71. Huang J, Marco E, Pinello L, Yuan G-C. 2015. Predicting chromatin organization using histone marks. Genome Biol 16: 162.
72. Melo CA, Drost J, Wijchers PJ, van de Werken H, et al. 2013. ERNAs are required for p53-dependent enhancer activity and gene transcription. Mol Cell 49: 524–35.
73. Lam MTY, Cho H, Lesch HP, Gosselin D, et al. 2013. Rev-Erbs repress macrophage gene expression by inhibiting enhancer-directed transcription. Nature 498: 511–5.
74. Lai F, Orom UA, Cesaroni M, Beringer M, et al. 2013. Activating RNAs associate with Mediator to enhance chromatin architecture and transcription. Nature 494: 497–501.
75. Li W, Notani D, Ma Q, Tanasa B, et al. 2013. Functional roles of enhancer RNAs for oestrogen-dependent transcriptional activation. Nature 498: 516–20.
76. Mousavi K, Zare H, Dell'orso S, Grontved L, et al. 2013. ERNAs promote transcription by establishing chromatin accessibility at defined genomic loci. Mol Cell 51: 606–17.
77. Schaukowitch K, Joo J-Y, Liu X, Watts JK, et al. 2014. Enhancer RNA facilitates NELF release from immediate early Genes. Mol Cell 56: 29–42.
78. IIott NE, Heward JA, Roux B, Tsitsiou E, et al. 2014. Long non-coding RNAs and enhancer RNAs regulate the lipopolysaccharide-induced inflammatory response in human monocytes. Nat Commun 5: 3979.
79. Hsieh C-L, Fei T, Chen Y, Li T, et al. 2014. Enhancer RNAs participate in androgen receptor-driven looping that selectively enhances gene activation. Proc Natl Acad Sci USA 111: 7319–24.
80. Sigova AA, Abraham BJ, Ji X, Molinie B, et al. 2015. Transcription factor trapping by RNA in gene regulatory elements. Science 350: 978–81.
81. Cloutier SC, Wang S, Ma WK, Al Husini N, et al. 2016. Regulated formation of lncRNA-DNA hybrids enables faster transcriptional induction and environmental adaptation. Mol Cell 61: 393–404.
82. Andersson R, Refsing Andersen P, Valen E, Core LJ, et al. 2014. Nuclear stability and transcriptional directionality separate functionally distinct RNA species. Nat Commun 5: 5336.
83. Lai F, Gardini A, Zhang A, Shiekhattar R. 2015. Integrator mediates the biogenesis of enhancer RNAs. Nature 525: 399–403.
84. Paralkar VR, Taborda CC, Huang P, Yao Y, et al. 2016. Unlinking an lncRNA from its associated cis element. Mol Cell 62: 104–10.
85. Kornienko AE, Guenzl PM, Barlow DP, Pauler FM. 2013. Gene regulation by the act of long non-coding RNA transcription. BMC Biol 11: 59.
86. Kolovos P, Knoch TA, Grosveld FG, Cook PR, et al. 2012. Enhancers and silencers: an integrated and simple model for their function. Epigenetics Chromatin 5: 1–8.
87. Li G, Ruan X, Auerbach RK, Sandhu KS, et al. 2012. Extensive promoter-centered chromatin interactions provide a topological basis for transcription regulation. Cell 148: 84–98.
88. Andersson R, Sandelin A, Danko CG. 2015. A unified architecture of transcriptional regulatory elements. Trends Genet 31: 426–33.
89. Moorman C, Sun LV, Wang J, de Wit E, et al. 2006. Hotspots of transcription factor colocalization in the genome of Drosophila melanogaster. Proc Natl Acad Sci USA 103: 12027–32.
90. Xie D, Boyle AP, Wu L, Zhai J, et al. 2013. Dynamic trans-acting factor colocalization in human cells. Cell 155: 713–24.
91. Chen H, Li H, Liu F, Zheng X, et al. 2015. An integrative analysis of TFBS-clustered regions reveals new transcriptional regulation models on the accessible chromatin landscape. Sci Rep 5: 8465.
92. Kvon EZ, Stampfel G, Yanez-Cuna JO, Dickson BJ, et al. 2012. HOT regions function as patterned developmental enhancers and have a distinct cis-regulatory signature. Genes Dev 26: 908–13.
93. Smith RP, Taher L, Patwardhan RP, Kim MJ, et al. 2013. Massively parallel decoding of mammalian regulatory sequences supports a flexible organizational model. Nat Genet 45: 1021–8.
94. Scholes C, DePace AH, Sanchez A. 2016. Integrating regulatory information via combinatorial control of the transcription cycle. bioRxiv, doi: 10.1101/039339
95. Levo M, Segal E. 2014. In pursuit of design principles of regulatory sequences. Nat Rev Genet 15: 453–68.
96. White MA. 2015. Understanding how cis-regulatory function is encoded in DNA sequence using massively parallel reporter assays and designed sequences. Genomics 106: 165–70.
97. Inoue F, Ahituv N. 2015. Decoding enhancers using massively parallel reporter assays. Genomics 106: 159–64.
98. Patwardhan RP, Hiatt JB, Witten DM, Kim MJ, et al. 2012. Massively parallel functional dissection of mammalian enhancers in vivo. Nat Biotechnol 30: 265–70.
99. Arnold CD, Gerlach D, Stelzer C, Boryn LM, et al. 2013. Genome-wide quantitative enhancer activity maps identified by STARR-seq. Science 339: 1074–7.
100. Kwasnieski JC, Mogno I, Myers CA, Corbo JC, et al. 2012. Complex effects of nucleotide variants in a mammalian cis-regulatory element. Proc Natl Acad Sci USA 109: 19498–503.
101. Sharon E, Kalma Y, Sharp A, Raveh-Sadka T, et al. 2012. Inferring gene regulatory logic from high-throughput measurements of thousands of systematically designed promoters. Nat Biotechnol 30: 521–30.
102. Murtha M, Tokcaer-Keskin Z, Tang Z, Strino F, et al. 2014. FIREWACh: high-throughput functional detection of transcriptional regulatory modules in mammalian cells. Nat Methods 11: 559–65.
103. Dickel DE, Zhu Y, Nord AS, Wylie JN, et al. 2014. Function-based identification of mammalian enhancers using site-specific integration. Nat Methods 11: 566–71.
104. Akhtar W, de Jong J, Pindyurin AV, Pagie L, et al. 2013. Chromatin position effects assayed by thousands of reporters integrated in parallel. Cell 154: 914–27.
105. Melnikov A, Murugan A, Zhang X, Tesileanu T, et al. 2012. Systematic dissection and optimization of inducible enhancers in human cells using a massively parallel reporter assay. Nat Biotechnol 30: 271–7.
106. Kheradpour P, Ernst J, Melnikov A, Rogov P, et al. 2013. Systematic dissection of regulatory motifs in 2000 predicted human enhancers using a massively parallel reporter assay. Genome Res 23: 800–11.
107. Patwardhan RP, Lee C, Litvin O, Young DL, et al. 2009. High-resolution analysis of DNA regulatory elements by synthetic saturation mutagenesis. Nat Biotechnol 27: 1173–5.
108. Gisselbrecht SS, Barrera LA, Porsch M, Aboukhalil A, et al. 2013. Highly parallel assays of tissue-specific enhancers in whole Drosophila embryos. Nat Methods 10: 774–80.
109. Vanhille L, Griffon A, Maqbool MA, Zacarias-Cabeza J, et al. 2015. High-throughput and quantitative assessment of enhancer activity in mammals by CapStarr-seq. Nat Commun 6: 6905.
110. Canver MC, Smith EC, Sher F, Pinello L, et al. 2015. BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis. Nature 527: 192–7.
111. Ptashne M, Gann A. 1997. Transcriptional activation by recruitment. Nature 386: 569–77.
112. Stampfel G, Kazmar T, Frank O, Wienerroither S, et al. 2015. Transcriptional regulators form diverse groups with context-dependent regulatory functions. Nature 528: 1–8.
113. Keung AJ, Bashor CJ, Kiriakov S, Collins JJ, et al. 2014. Using targeted chromatin regulators to engineer combinatorial and spatial transcriptional regulation. Cell 158: 110–20.
114. Diao Y, Li B, Meng Z, Jung I, et al. 2016. A new class of temporarily phenotypic enhancers identified by CRISPR/Cas9-mediated genetic screening. Genome Res 26: 397–405.
115. Findlay GM, Boyle EA, Hause RJ, Klein JC, et al. 2014. Saturation editing of genomic regions by multiplex homology-directed repair. Nature 513: 120–3.
116. Nelles DA, Fang MY, O'Connell MR, Xu JL, et al. 2016. Programmable RNA tracking in live cells with CRISPR/Cas9. Cell 165: 488–96.
117. Chen B, Gilbert LA, Cimini BA, Schnitzbauer J, et al. 2013. Dynamic imaging of genomic loci in living human cells by an optimized CRISPR/Cas system. Cell 155: 1479–91.
118. Ma H, Tu L-C, Naseri A, Huisman M, et al. 2016. Multiplexed labeling of genomic loci with dCas9 and engineered sgRNAs using CRISPRainbow. Nat Biotechnol 34: 528–30.
119. Perez-Pinera P, Kocak DD, Vockley CM, Adler AF, et al. 2013. RNA-guided gene activation by CRISPR-Cas9-based transcription factors. Nat Methods 10: 973–6.
120. Zalatan JG, Lee ME, Almeida R, Gilbert LA, et al. 2015. Engineering complex synthetic transcriptional programs with CRISPR RNA scaffolds. Cell 160: 339–50.
121. Shechner DM, Hacisuleyman E, Younger ST, Rinn JL. 2015. Multiplexable, locus-specific targeting of long RNAs with CRISPR-Display. Nat Methods 12: 664–70.